The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide

被引:36
|
作者
Siddiqui, AH
Harris, AD
Hebden, J
Wilson, PD
Morris, JG
Roghmann, MC
机构
[1] VA Maryland Hlth Care Syst, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Healthcare Outcomes Res, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[4] Univ Maryland, Med Syst, Baltimore, MD 21201 USA
关键词
D O I
10.1067/mic.2002.118616
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Vancomycin-resistant enterococci (VRE) have become a major cause of nosocomial Infections and are now endemic in many geographic areas, The aim of this study was to describe the effect of active surveillance for patients with VRE in high-risk units on the VRE incidence rate hospital-wide. Methods: We determined 4 time periods based on the intervention of active surveillance: preactive surveillance (period 1), active surveillance (period 2), no active surveillance (period 3), and reinstutition of active surveillance (period 4). VRE incidence rates based on first clinical culture for VRE per 10,000 patient days for each of these periods and incidence rate ratios were then calculated. Results: Active surveillance in high-risk units was associated with a significant reduction in VRE incidence hospital-wide in 2 of the 3 comparisons made. The incidence rate ratio when comparing the first period of active surveillance (period 2) to the preactive surveillance period (period 1) was 0.63 (95 % Cl, 0.38-1.1) it was 0.36 (95 % Cl, 0.23-0.55) when comparing the first period of active surveillance (period 2) to the subsequent period (period 3) and 0.68 (95% Cl, 0.54-0.85) when comparing the second period of active surveillance (period 4) to the prior period without active surveillance periods, Conclusions: Active surveillance culturing for VRE in the high risk-units prevented further VRE transmission, as evidenced by a significant increase in hospital-wide incidence rates when active surveillance was discontinued and a significant decrease in incidence rates when it was restarted.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 50 条
  • [21] Emergence of vancomycin-resistant enterococci
    Rice, LB
    EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 183 - 187
  • [22] Vancomycin-resistant Enterococci in neonates
    Yüce, A
    Karaman, M
    Gülay, Z
    Yulug, N
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (11) : 803 - 805
  • [23] CONTROLLING VANCOMYCIN-RESISTANT ENTEROCOCCI
    BOYCE, JM
    MERMEL, LA
    ZERVOS, MJ
    RICE, LB
    POTTERBYNOE, G
    GIORGIO, C
    MEDEIROS, AA
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1995, 16 (11): : 634 - 637
  • [24] Vancomycin-resistant enterococci in hospitals
    Ferguson, John
    MICROBIOLOGY AUSTRALIA, 2014, 35 (01) : 37 - 43
  • [25] Vancomycin-resistant enterococci in vegetarians
    vandenBraak, N
    Kreft, D
    vanBelkum, A
    Verbrugh, H
    Endtz, H
    LANCET, 1997, 350 (9071): : 146 - 147
  • [26] Detection of vancomycin-resistant enterococci
    Mori, S
    JOURNAL OF THE FOOD HYGIENIC SOCIETY OF JAPAN, 1999, 40 (04): : J340 - J341
  • [27] Experience report on surveillance of vancomycin-resistant enterococci
    MM Baraldi
    CZ Talala
    MM Simonetti
    CM Santoro
    BMC Proceedings, 5 (Suppl 6)
  • [28] Vancomycin-resistant enterococci: Comment
    Rapp, RP
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (12) : 1500 - 1500
  • [29] Approaches to vancomycin-resistant enterococci
    Torres-Viera, C
    Dembry, LM
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) : 541 - 547
  • [30] Vancomycin-resistant enterococci: A review
    Joshi, N
    Milfred, D
    Caputo, G
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (09) : 528 - 535